Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavia V Castelino

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Clinical Rheumatology|October 23, 2020
Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?Tracy M Frech, John M VanBuren, Emily Startup, et al.
Arthritis Care & Research|May 26, 2017
Barriers and Facilitators of Mentoring for Trainees and Early Career Investigators in Rheumatology Research: Current State, Identification of Needs, and Road Map to an Inter-Institutional Adult Rheumatology Mentoring ProgramAlexis Ogdie, Jeffrey A Sparks, Sheila T Angeles-Han, et al.
International Journal of Rheumatic Diseases|November 29, 2021
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registryFlavia V Castelino, John M VanBuren, Emily Startup, et al.
Arthritis Research & Therapy|June 15, 2021
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohortSara Jaafar, Alain Lescoat, Suiyuan Huang, et al.
Clinical and Experimental Rheumatology|July 27, 2023
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
The Lancet. Rheumatology|April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort studyMonique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
NEJM Evidence|May 1, 2023
E-Cigarette Use, Small Airway Fibrosis, and Constrictive BronchiolitisLida P Hariri, Bess M Flashner, David J Kanarek, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Current Respiratory Medicine Reviews|November 17, 2015
Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)Shikha Mittoo, Sid Frankel, Daphne LeSage, et al.
Respiratory Research|January 9, 2023
Expert consensus on the management of systemic sclerosis-associated interstitial lung diseaseFranck F Rahaghi, Vivien M Hsu, Robert J Kaner, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Clinical Rheumatology|October 23, 2020
Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?Tracy M Frech, John M VanBuren, Emily Startup, et al.
Arthritis Care & Research|May 26, 2017
Barriers and Facilitators of Mentoring for Trainees and Early Career Investigators in Rheumatology Research: Current State, Identification of Needs, and Road Map to an Inter-Institutional Adult Rheumatology Mentoring ProgramAlexis Ogdie, Jeffrey A Sparks, Sheila T Angeles-Han, et al.
International Journal of Rheumatic Diseases|November 29, 2021
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registryFlavia V Castelino, John M VanBuren, Emily Startup, et al.
Arthritis Research & Therapy|June 15, 2021
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohortSara Jaafar, Alain Lescoat, Suiyuan Huang, et al.
Clinical and Experimental Rheumatology|July 27, 2023
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
The Lancet. Rheumatology|April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort studyMonique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
NEJM Evidence|May 1, 2023
E-Cigarette Use, Small Airway Fibrosis, and Constrictive BronchiolitisLida P Hariri, Bess M Flashner, David J Kanarek, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Current Respiratory Medicine Reviews|November 17, 2015
Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)Shikha Mittoo, Sid Frankel, Daphne LeSage, et al.
Respiratory Research|January 9, 2023
Expert consensus on the management of systemic sclerosis-associated interstitial lung diseaseFranck F Rahaghi, Vivien M Hsu, Robert J Kaner, et al.
Pageof 5